FDA-Registered facilities
Why the MRA? I have got a few slides here that give some data. I am going to, at the outset, qualify the data. What I want you to notice is that there is a huge fraction of our registered human drug facility inventory that is not in the US – nobody is shocked by that – and that a big portion of them are not in the European Union.
However, there is a big enough number there that it makes this overall beneficial to us. If we can do fewer inspections in the European Union, then we can save that and spend that same amount of resources or inspection capacity in other parts of the world – including, by the way, the US.
Monthly Update/ September 2023
www.ipq.org
Monthly Update/Facilities
5